Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase I/IIa: Allogeneic Bone Marrow Derived Mesenchymal Stem Cells Transplantation For Refractory Systemic Lupus Erythematosus

NCT00698191 is registered in ClinicalTrials.gov with Nanjing Medical University as lead sponsor.

NCT NCT00698191
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00698191 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase I/IIa: Allogeneic Bone Marrow Derived Mesenchymal Stem Cells Transplantation For Refractory Systemic Lupus Erythematosus
Lead sponsor
Nanjing Medical University
Phase
Phase 1/2
Overall status
Unknown status
Start date
March 31, 2007
Completion date
December 31, 2012
Enrollment
20 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

refractory systemic lupus erythematosus